Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Huong Ung"'
Publikováno v:
Emerging Infectious Diseases, Vol 8, Iss 12, Pp 1501-1503 (2002)
Fluoroquinolone-resistant Campylobacter jejuni has been observed worldwide and is now being seen in the United States. Among patients in our health-care system in Pennsylvania, fluoroquinolone-resistant C. jejuni were not observed from 1982 to 1992;
Externí odkaz:
https://doaj.org/article/e615da4c322b4d06b92dfdbd145c5132
Autor:
I, Nachamkin, P, Arzarte Barbosa, P Arzate, Barbosa, Huong, Ung, H, Ung, C, Lobato, A, Gonzalez Rivera, A Gonzalez, Rivera, P, Rodriguez, A, Garcia Briseno, A Garcia, Briseno, L Maria, Cordero, L, Garcia Perea, L Garcia, Perea, J Carlos, Perez, M, Ribera, P Chico, Aldama, G Dávila, Guitérrez, L Flores, Sarnat, M Ruiz, García, J, Veitch, C, Fitzgerald, D R, Cornblath, D, Cornblath, M, Rodriguez Pinto, M Rodriguez, Pinto, J W, Griffin, H J, Willison, A K, Asbury, G M, McKhann
Publikováno v:
Neurology. 69:1665-1671
Background: Guillain-Barre syndrome (GBS) is an acute, immune-mediated flaccid paralysis frequently associated with Campylobacter infection. Of two predominant GBS subtypes, a demyelinating subtype (acute inflammatory demyelinative polyneuropathy [AI
Autor:
Martina M. Prendergast, Irving Nachamkin, Kazim A. Sheikh, Huong Ung, Ming Li, Anthony P. Moran, Jirong Liu
Publikováno v:
Infection and Immunity. 70:5299-5303
GM 1 - and GD 1a -like ganglioside mimicry in Campylobacter jejuni lipooligosaccharide (LOS) is considered to be involved in the pathogenesis of Campylobacter -induced Guillain-Barré syndrome (GBS). Compared with gastroenteritis-related isolates, G
Autor:
Hugh J. Willison, G. R. Wang, Irving Nachamkin, Huong Ung, John W. Griffin, David R. Cornblath, Arthur K. Asbury, Tony W. Ho, Guy M. McKhann, C. Y. Li, R. C. Liu, J. Veitch
Publikováno v:
Annals of Neurology. 45:168-173
Immunopathological studies suggest that the target of immune attack is different in the subtypes of Guillain-Barre syndrome (GBS). In acute motor axonal neuropathy (AMAN), the attack appears directed against the axolemma and nodes of Ranvier. In acut
Publikováno v:
Emerging Infectious Diseases. Dec2002, Vol. 8 Issue 12, p1501. 3p. 3 Graphs.
Publikováno v:
Emerging Infectious Diseases, Vol 8, Iss 12, Pp 1501-1503 (2002)
Fluoroquinolone-resistant Campylobacter jejuni has been observed worldwide and is now being seen in the United States. Among patients in our health-care system in Pennsylvania, fluoroquinolone-resistant C. jejuni were not observed from 1982 to 1992;
Autor:
Heinz, Reiske, Baoquan, Sui, Huong, Ung-Medoff, Robert, Donahue, Wu-Bo, Li, Michael, Goldblatt, Limin, Li, Michael S, Kinch
Publikováno v:
Analytical and quantitative cytology and histology. 32(2)
To utilize a powerful new technology for target discovery, Random Homozygous Gene Perturbation (RHGP), and to identify novel targets that cause tumor cells to become chemoresistant.RHGP was used to identify and validate genetic changes that cause che
Autor:
Nancy J. Cox, Lawrence B. Schonberger, Irving Nachamkin, Adrian T. Corcoran, Collette Fitzgerald, Anthony P. Moran, Huong Ung, John K. Iskander, Robert T. Chen, Sean V. Shadomy
Publikováno v:
The Journal of infectious diseases. 198(2)
Background. Receipt of an A/NJ/1976/H1N1 "swine flu" vaccine in 1976, unlike receipt of influenza vaccines used in subsequent years, was strongly associated with the development of the neurologic disorder Guillain-Barre syndrome (GBS). Anti-gangliosi
Autor:
Peter J. Coloe, Malcolm J. McConville, John H. Patterson, Irving Nachamkin, Benjamin N. Fry, Viraj N. Perera, Huong Ung
Publikováno v:
FEMS immunology and medical microbiology. 50(1)
Campylobacter jejuni is recognized as the most common identifiable pathogen associated with the development of Guillain-Barre syndrome (GBS), an acute autoimmune-mediated disease affecting the peripheral nervous system. The immune response to ganglio
Autor:
Ming Li, Po Ki Yuen, Irving Nachamkin, Peter Wilding, Huong Ung, Nicholas J. Panaro, Larry J. Kricka
The Agilent 2100 bioanalyzer (Agilent Technologies, Palo Alto, Calif.) utilizes capillary electrophoresis on a microchip device (LabChip 7500; Caliper Technologies, Mountain View, Calif.) that is capable of rapidly sizing small DNA fragments. To dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0c8935a6277cf4b96795924b1546cdd
https://europepmc.org/articles/PMC87813/
https://europepmc.org/articles/PMC87813/